Business
Director/PDMR Shareholding
Spire Healthcare Group plc announced on March 18, 2026, that executive directors Justin Ash and Harbant Samra were granted nil cost options under the Long Term Incentive Plan on March 17, 2026. Justin Ash received an award for up to 736,733 ordinary shares, and Harbant Samra received an award for up to 451,653 ordinary shares, with both awards representing 200% of their current base salary. The actual number of shares vesting will depend on performance conditions set to be finalized and published later, with a share price of 185.08 pence used for the award calculation, and a further two-year holding period will apply post-vesting. Disclaimer*
About this update from Spire Healthcare Group Plc
[{"type":"text","content":"\n\nSpire Healthcare Group plc (the Company)\nNotification of Transactions of Persons Discharging Managerial Responsibilities\n \n18 March 2026\n \nGrant of Long Term Incentive Plan (LTIP) awards\nThe Company announces that, on 17 March 2026, performance share awards were granted over the Company's ordinary shares in the form of nil cost options to the following Executive Directors of the Company, under the rules of the Company's Long Term Incentive Plan.\n \nExecutive Director Maximum number of shares under award\nJustin Ash 736,733\nHarbant Samra 451,653\n \nThe number of shares set out above represents 200% of current base salary. It is the maximum number which may vest under the LTIP awards following the end of the performance period (31 December 2028). The shareholder-approved Remuneration Policy permits awards of up to 200% of base salary for Executive Directors.\n \nThe actual number of shares which vest will depend on the extent to which the relevant performance conditions have been satisfied.\n \nGiven the current evaluation of actions to drive shareholder value, the Remuneration Committee is taking further time to carefully consider and determine the LTIP performance conditions and targets to ensure they are fully aligned to the Company's forward-looking strategy. Once finalised, the 2026 LTIP performance conditions and targets will be published on the Company's website, and they will be disclosed in the 2026 Directors' Remuneration Report.\n \nThe share price used to determine the number of shares under the LTIP Awards was 185.08 pence, being the average of the mid-market closing share price over the five trading days ending on 16 March 2026.\n \n \nNotes:\n \n1) For both Executive Directors the 2026 LTIP awards described above will also be subject to a further two-year holding period following the vesting date.\n2) The actual number of shares w...